1254426

Reproductive Technologies, Inc. — FEI 3003343209

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 18, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Berkeley, CA (United States)

Citations

IDCFRDescription
1222921 CFR 1271.50(a)Determination based on screening and testing